A RNA molecule that specifically inhibits G-protein coupled receptor kinase 2 in vitro

G. Mayer, Bernhard Wulffen, Christian Huber, Joerg Brockmann, Birgit Flicke, Lars Neumann, Doris Hafenbradl, Bert M. Klebl

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)


G-protein-coupled receptors are desensitized by a two-step process. In a first step, G-protein-coupled receptor kinases (GRKs) phosphorylate agonist-activated receptors that subsequently bind to a second class of proteins, the arrestins. GRKs can be classified into three subfamilies, which have been implicated in various diseases. The physiological role(s) of GRKs have been difficult to study as selective inhibitors are not available. We have used SELEX (systematic evolution of ligands by exponential enrichment) to develop RNA aptamers that potently and selectively inhibit GRK2. This process has yielded an aptamer, C13, which bound to GRK2 with a high affinity and inhibited GRK2-catalyzed rhodopsin phosphorylation with an IC50 of 4.1 nM. Phosphorylation of rhodopsin catalyzed by GRK5 was also inhibited, albeit with 20-fold lower potency (IC50 of 79 nM). Furthermore, C13 reveals significant specificity, since almost no inhibitory activity was detectable testing it against a panel of 14 other kinases. The aptamer is two orders of magnitude more potent than the best GRK2 inhibitors described previously and shows high selectivity for the GRK family of protein kinases.
Original languageEnglish
Pages (from-to)524-534
Number of pages10
JournalRNA - A Publication of the RNA Society
Issue number3
Publication statusPublished - Mar 2008


  • in vitro selection
  • aptamer
  • GRK2
  • kinase inhibitor


Dive into the research topics of 'A RNA molecule that specifically inhibits G-protein coupled receptor kinase 2 in vitro'. Together they form a unique fingerprint.

Cite this